Cancer Biotherapy & Radiopharmaceuticals, 1557-8852

Tidskrift

Fler filtreringsmöjligheter
Fler filtreringsmöjligheter

Alla författare

Återställ
till
1 - 39 av 39Sidstorlek: 50
Sortera efter: Utgivningsår
  1. 2020

  2. Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223

    Diane S. Abou, Andrew Rittenbach, Ryan E. Tomlinson, Paige A. Finley, Benjamin Tsui, Brian W. Simons, Abhinav K. Jha, David Ulmert, Ryan C. Riddle & Daniel L.J. Thorek, 2020, I: Cancer Biotherapy and Radiopharmaceuticals. 35, 7, s. 520-529 10 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  3. 2018

  4. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Cu-Labeled Nanoparticles

    Renata Madru, Michael Budassi, Helene Benveniste, Hedok Lee, S David Smith, David J Schlyer, Paul Vaska, Linda Knutsson & Sven-Erik Strand, 2018 aug, I: Cancer Biotherapy & Radiopharmaceuticals. 33, 6, s. 213-220 8 s.

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  5. 2015

  6. Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.

    Jenny Nilsson, Monika Bauden, Jonas Nilsson, Sven-Erik Strand & Jörgen Elgqvist, 2015, I: Cancer Biotherapy & Radiopharmaceuticals. 30, 9, s. 386-394

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  7. 2014

  8. Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.

    Erika Elgström, Otto Ljungberg, Sophie Eriksson, Anders Örbom, Sven-Erik Strand, Tomas G Ohlsson, Rune Nilsson & Jan Tennvall, 2014, I: Cancer Biotherapy & Radiopharmaceuticals. 29, 4, s. 143-152

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  9. Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Erika Elgström, Tom Bäck, Tomas G Ohlsson, Holger Jensen, Rune Nilsson, Sture Lindegren & Jan Tennvall, 2014, I: Cancer Biotherapy & Radiopharmaceuticals. 29, 6, s. 238-246

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  10. 2012

  12. Repeated Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Tomas G Ohlsson, Rune Nilsson & Jan Tennvall, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 2, s. 134-140

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  13. Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.

    Susan Evans Axelsson, David Ulmert, Anders Örbom, Pernilla Peterson, Olle Nilsson, Johan Wennerberg, Joanna Strand, Karin Wingårdh, Tomas Olsson, Zandra Hagman, Vladimir Tolmachev, Anders Bjartell, Hans Lilja & Sven-Erik Strand, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 4, s. 243-251

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  14. Treatment with Unlabeled mAb BR96 After Radioimmunotherapy with (177)Lu-DOTA-BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Tomas G Ohlsson, Rune Nilsson & Jan Tennvall, 2012, I: Cancer Biotherapy & Radiopharmaceuticals. 27, 3, s. 175-182

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  15. 2009

  16. Development and evaluation of a pharmacokinetic model for prediction of radioimmunotherapy based on pretherapy data.

    Mattias Nickel, Sven-Erik Strand, Ola Lindén, Karin Wingårdh, Jan Tennvall & Katarina Sjögreen Gleisner, 2009, I: Cancer Biotherapy & Radiopharmaceuticals. 24, 1, s. 111-121

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  17. Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.

    Maria Bjurberg, Eva Henriksson, Eva Brun, Lars Ekblad, Tomas G Ohlsson, Arne Brun & Elisabeth Kjellén, 2009, I: Cancer Biotherapy & Radiopharmaceuticals. 24, 3, s. 327-332

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  18. Glomerular Filtration Rate After Alpha-Radioimmunotherapy with At-211-MX35-F(ab ')(2): A Long-Term Study of Renal Function in Nude Mice

    Tom Back, Boerje Haraldsson, Ragnar Hultborn, Holger Jensen, Martin Johansson, Sture Lindegren & Lars Jacobsson, 2009, I: Cancer Biotherapy & Radiopharmaceuticals. 24, 6, s. 649-658

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  19. 2008

  20. Evaluation of toxicity-reducing potential of ECAT in combination with drug-conjugated mAb BR96

    Linda Mårtensson, Rune Nilsson, Hans Olov Sjögren & Jan Tennvall, 2008, I: Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 520-520

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  21. Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.

    ER Nemecek, DJ Green, DR Fischer, JM Pagel, Y Lin, AK Gopal, LD Durack, JG Rajendran, DS Wilbur, Rune Nilsson, Bengt Sandberg & OW Press, 2008, I: Cancer Biotherapy & Radiopharmaceuticals. 23, 2, s. 181-191

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  23. Peptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results

    Michael Garkavij, Katarina Sjögreen Gleisner, Mattias Nickel, Tomas G Ohlsson, Karin Wingårdh & Jan Tennvall, 2008, I: Cancer Biotherapy and Radiopharmaceuticals. 23, 4, s. 524-525

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  24. Quantitative serial imaging of an I-124 anti-CEA monoclonal antibody in tumor-bearing mice

    James R. Bading, Magnus Horling, Lawrence E. Williams, David Colcher, Andrew Raubitschek & Sven-Erik Strand, 2008, I: Cancer Biotherapy & Radiopharmaceuticals. 23, 4, s. 399-409

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  25. 2007

  28. Optimization of energy-window settings for scatter correction in quantitative In-111 imaging: Comparison of measurements and Monte Carlo simulations

    Maria Holstensson, Cecilia Hindorf, Michael Ljungberg, Mike Partridge & Glenn D. Flux, 2007, I: Cancer Biotherapy & Radiopharmaceuticals. 22, 1, s. 136-142

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  29. Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread

    Cecilia Hindorf, Dimitris Emfietzoglou, Ola Lindén, Christos Bousis, Andreas Fotopoulos, Kostas Kostarelos & Glenn D. Flux, 2007, I: Cancer Biotherapy & Radiopharmaceuticals. 22, 3, s. 357-366

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  30. 2006

  32. Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin ((191)pt) in wistar rats.

    Kristina Norrgren, Maria Sjölin, Sven Bjorkman, Johan Areberg, Anders Johnsson, Leif Johansson & Sören Mattsson, 2006, I: Cancer Biotherapy & Radiopharmaceuticals. 21, 5, s. 528-534

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  33. 2005

  35. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.

    Ola Lindén, Jan Kurkus, Michael Garkavij, Eva Cavallin-Ståhl, Michael Ljungberg, Rune Nilsson, Tomas G Ohlsson, Bengt Sandberg, Sven-Erik Strand & Jan Tennvall, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 4, s. 457-466

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  37. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.

    Cecilia Hindorf, Dimitris Emfietzoglou, Ola Lindén, Kostas Kostarelos & Sven-Erik Strand, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 2, s. 224-230

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  38. Population biokinetic modeling of thyroid uptake and retention of radioiodine.

    Johan Areberg, H Jönsson & Sören Mattsson, 2005, I: Cancer Biotherapy & Radiopharmaceuticals. 20, 1, s. 1-10

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  40. 2004

  41. Absorbed dose distribution in glioma tumors in rat brain after therapeutic intratumoral injection of 201Tl-chloride.

    Kaj Ljunggren, Xiaowei Liu, Kjell Erlandsson, Michael Ljungberg, Leif Salford & Sven-Erik Strand, 2004, I: Cancer Biotherapy & Radiopharmaceuticals. 19, 5, s. 562-569

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  42. Blood pharmacokinetics of various mabs labeled with a new tri-chelating reagent for simultaneous conjugation with DOTA and biotin prior to radiolabeling

    Zhongmin Wang, Linda Mårtensson, Rune Nilsson, Pär-Ola Bendahl, L Lindgren, Tomas G Ohlsson, H O Sjögren, Sven-Erik Strand & Jan Tennvall, 2004, I: Cancer Biotherapy and Radiopharmaceuticals. 19, 4, s. 540-541

    Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract

  43. 2003

  45. Accuracy of the quantification of organ activity from planar gamma camera images

    Kristina Norrgren, SL Svegborn, Johan Areberg & Sören Mattsson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 1, s. 125-131

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  46. Biokinetics of iodide in man: Refinement of current ICRP dosimetry models

    L Johansson, Sigrid Leide Svegborn, Sören Mattsson & Bertil Nosslin, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 445-450

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  47. Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.

    Zhongmin Wang, Michael Garkavij, Tomas G Ohlsson, Sven-Erik Strand, Hans Olov Sjögren & Jan Tennvall, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 365-375

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  48. Calibration of a radioactive ink-based stack phantom and its applications in nuclear medicine.

    H El-Ali, Michael Ljungberg, Sven-Erik Strand, John Palmer, Lars Malmgren & J Nilsson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 2, s. 201-207

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  50. Internal radionuclide dosimetry: diagnostic and therapeutic nuclear medicine, occupational and environmental exposures. Differences and similarities.

    Sören Mattsson, Lars Jacobsson & Lennart Johansson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 421-424

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

  51. Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism.

    Helene Jönsson & Sören Mattsson, 2003, I: Cancer Biotherapy & Radiopharmaceuticals. 18, 3, s. 473-479

    Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift